| scholarly article | Q13442814 |
| P2093 | author name string | Bally M | |
| Lazdunski A | |||
| Carrère J | |||
| Chazalette JP | |||
| Jaffar-Bandjee MC | |||
| Galabert C | |||
| P2860 | cites work | Production of mucoid microcolonies by Pseudomonas aeruginosa within infected lungs in cystic fibrosis | Q33903005 |
| Contribution of toxin A and elastase to virulence of Pseudomonas aeruginosa in chronic lung infections of rats. | Q33913379 | ||
| Longitudinal study of immune response to Pseudomonas aeruginosa antigens in cystic fibrosis | Q37103907 | ||
| Inflammation in the lung in cystic fibrosis. A vicious cycle that does more harm than good? | Q37289738 | ||
| The impact of respiratory viral infections in patients with cystic fibrosis. | Q37289804 | ||
| Respiratory infections in cystic fibrosis patients caused by virus, chlamydia and mycoplasma--possible synergism with Pseudomonas aeruginosa | Q37909036 | ||
| Cystic fibrosis. 1. Pseudomonas aeruginosa infection in cystic fibrosis and its management | Q38007627 | ||
| Antibodies to proteases and exotoxin A of Pseudomonas aeruginosa in patients with cystic fibrosis: Demonstration by radioimmunoassay | Q39614519 | ||
| Bacteriology of sputum in cystic fibrosis: evaluation of dithiothreitol as a mucolytic agent. | Q40230334 | ||
| Sputum changes associated with therapy for endobronchial exacerbation in cystic fibrosis | Q40787456 | ||
| Effects of human neutrophil elastase and Pseudomonas aeruginosa proteinases on human respiratory epithelium | Q41161986 | ||
| Pseudomonas aeruginosa infection in cystic fibrosis. Diagnostic and prognostic significance of Pseudomonas aeruginosa precipitins determined by means of crossed immunoelectrophoresis | Q41254653 | ||
| Elastase from polymorphonuclear leucocytes: a regulatory enzyme in immune complex disease | Q41354550 | ||
| Co-existence of colonies with different serotypes and other biological characteristics in clinical isolates of Pseudomonas aeruginosa | Q43567526 | ||
| The contribution of exoproducts to virulence of Pseudomonas aeruginosa | Q43958510 | ||
| Is anti-Pseudomonas therapy warranted in acute respiratory exacerbations in children with cystic fibrosis? | Q44379999 | ||
| Respiratory tract colonization with Pseudomonas aeruginosa in cystic fibrosis: correlations between anti-Pseudomonas aeruginosa antibody levels and pulmonary function | Q44472190 | ||
| Proteolytic inactivation of alpha 1-proteinase inhibitor in infected bronchial secretions from patients with cystic fibrosis. | Q44585913 | ||
| Inactivation of human bronchial mucosal proteinase inhibitor by Pseudomonas aeruginosa elastase | Q44605544 | ||
| Detection of proteases of Pseudomonas aeruginosa in immune complexes isolated from sputum of cystic fibrosis patients. | Q44962805 | ||
| Epidemiological investigations of the respiratory tract bacteriology in patients with cystic fibrosis | Q45138163 | ||
| Direct double antibody sandwich immunoassay for Pseudomonas aeruginosa elastase | Q46574904 | ||
| Purification of human plasma alpha 1-proteinase inhibitor and its inactivation by Pseudomonas aeruginosa elastase | Q50923543 | ||
| Ceftazidime monotherapy vs. combined therapy in Pseudomonas pulmonary infections in cystic fibrosis. | Q54404421 | ||
| Clinical and Bacteriological Responses to Three Antibiotic Regimens for Acute Exacerbations of Cystic Fibrosis: Tlcarcillln-Tobramycin, Azlocillin-Tobramycin, and Azlocillin-Placebo | Q54501407 | ||
| Reduction of sputum Pseudomonas aeruginosa density by antibiotics improves lung function in cystic fibrosis more than do bronchodilators and chest physiotherapy alone | Q67285211 | ||
| Mucosal immunity to Pseudomonas aeruginosa alginate in cystic fibrosis | Q68117847 | ||
| A double-blind controlled trial of anti-Pseudomonas chemotherapy of acute respiratory exacerbations in patients with cystic fibrosis | Q70161420 | ||
| Association of systemic immune complexes, complement activation, and antibodies to Pseudomonas aeruginosa lipopolysaccharide and exotoxin A with mortality in cystic fibrosis | Q70282879 | ||
| Proteases of Pseudomonas aeruginosa in patients with cystic fibrosis | Q70431168 | ||
| Granulocyte neutral proteases and Pseudomonas elastase as possible causes of airway damage in patients with cystic fibrosis | Q70480655 | ||
| Molecular epidemiology of chronic pulmonary colonisation by Pseudomonas aeruginosa in cystic fibrosis | Q70524997 | ||
| Immunoenzymometric Assays for Alkaline Protease and Exotoxin A from Pseudomonas aeruginosa: Development and Use in Detecting Exoproteins in Clinical Isolates from Patients with Cystic Fibrosis | Q72109990 | ||
| Elevated exoenzyme expression by Pseudomonas aeruginosa is correlated with exacerbations of lung disease in cystic fibrosis | Q72821258 | ||
| Ultrasonic method of sputum homogenization and its application in the study of the enzymic content of sputum | Q72894087 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Pseudomonas aeruginosa | Q31856 |
| cystic fibrosis | Q178194 | ||
| P304 | page(s) | 924-929 | |
| P577 | publication date | 1995-04-01 | |
| P1433 | published in | Journal of Clinical Microbiology | Q4041880 |
| P1476 | title | Production of elastase, exotoxin A, and alkaline protease in sputa during pulmonary exacerbation of cystic fibrosis in patients chronically infected by Pseudomonas aeruginosa | |
| P478 | volume | 33 |
| Q28553135 | A Selective Irreversible Inhibitor of Furin Does Not Prevent Pseudomonas Aeruginosa Exotoxin A-Induced Airway Epithelial Cytotoxicity |
| Q28492964 | Activation of the epithelial sodium channel (ENaC) by the alkaline protease from Pseudomonas aeruginosa |
| Q39827029 | Adhesion of Pseudomonas aeruginosa to respiratory mucins and expression of mucin-binding proteins are increased by limiting iron during growth. |
| Q33990985 | Assembly of XcpR in the cytoplasmic membrane is required for extracellular protein secretion in Pseudomonas aeruginosa |
| Q35763213 | Calcium-induced folding and stabilization of the Pseudomonas aeruginosa alkaline protease |
| Q33796573 | Carbapenem-resistant Pseudomonas aeruginosa: association with virulence genes and biofilm formation |
| Q24646990 | Cif is negatively regulated by the TetR family repressor CifR |
| Q36135733 | Cystic fibrosis-adapted Pseudomonas aeruginosa quorum sensing lasR mutants cause hyperinflammatory responses. |
| Q30354742 | Dual-seq transcriptomics reveals the battle for iron during Pseudomonas aeruginosa acute murine pneumonia. |
| Q39508338 | Elastase deficiency phenotype of Pseudomonas aeruginosa canine otitis externa isolates |
| Q36072775 | Elevated furin levels in human cystic fibrosis cells result in hypersusceptibility to exotoxin A-induced cytotoxicity |
| Q40211764 | Genome-Wide Survey of Pseudomonas aeruginosa PA14 Reveals a Role for the Glyoxylate Pathway and Extracellular Proteases in the Utilization of Mucin. |
| Q38741128 | Impairment of Pseudomonas aeruginosa Biofilm Resistance to Antibiotics by Combining the Drugs with a New Quorum-Sensing Inhibitor |
| Q35194638 | Modulation of the epithelial sodium channel (ENaC) by bacterial metalloproteases and protease inhibitors |
| Q42483056 | Molecular identification and detection of virulence genes among Pseudomonas aeruginosa isolated from different infectious origins |
| Q39479122 | P-113D, an antimicrobial peptide active against Pseudomonas aeruginosa, retains activity in the presence of sputum from cystic fibrosis patients |
| Q35913962 | Phenotypic characterization of clonal and nonclonal Pseudomonas aeruginosa strains isolated from lungs of adults with cystic fibrosis |
| Q35556206 | Positive correlation of algD transcription to lasB and lasA transcription by populations of Pseudomonas aeruginosa in the lungs of patients with cystic fibrosis. |
| Q27001070 | Pouring salt on a wound: Pseudomonas aeruginosa virulence factors alter Na+ and Cl- flux in the lung |
| Q37643058 | Pseudomonas aeruginosa Lifestyle: A Paradigm for Adaptation, Survival, and Persistence |
| Q36108849 | Pseudomonas aeruginosa quorum sensing molecules correlate with clinical status in cystic fibrosis |
| Q28343591 | Pseudomonas aeruginosa quorum-sensing signal molecule N-(3-oxododecanoyl)-L-homoserine lactone inhibits expression of P2Y receptors in cystic fibrosis tracheal gland cells |
| Q34120303 | Pulmonary inflammation induced by Pseudomonas aeruginosa lipopolysaccharide, phospholipase C, and exotoxin A: role of interferon regulatory factor 1. |
| Q33704257 | Regulation of acetyl-CoA synthetase transcription by the CrbS/R two-component system is conserved in genetically diverse environmental pathogens. |
| Q28493170 | Roles of Pseudomonas aeruginosa las and rhl quorum-sensing systems in control of elastase and rhamnolipid biosynthesis genes |
| Q42949257 | Secretion of proteases by Pseudomonas aeruginosa biofilms exposed to ciprofloxacin. |
| Q40883169 | Selection of Single-Stranded DNA Molecular Recognition Elements against Exotoxin A Using a Novel Decoy-SELEX Method and Sensitive Detection of Exotoxin A in Human Serum |
| Q24802489 | State of the Art: Why do the lungs of patients with cystic fibrosis become infected and why can't they clear the infection? |
| Q58739509 | Testing the neutral theory of biodiversity with the microbiome dataset from cystic fibrosis patients |
| Q35949789 | The Pseudomonas aeruginosa LasB metalloproteinase regulates the human urokinase-type plasminogen activator receptor through domain-specific endoproteolysis |
| Q33747175 | The Pseudomonas aeruginosa quorum-sensing signal molecule N-(3-oxododecanoyl)-L-homoserine lactone has immunomodulatory activity |
| Q24675645 | The Pseudomonas aeruginosa secreted protein PA2934 decreases apical membrane expression of the cystic fibrosis transmembrane conductance regulator |
| Q61809676 | Tobramycin reduces key virulence determinants in the proteome of Pseudomonas aeruginosa outer membrane vesicles |
| Q35143420 | Using bacterial biomarkers to identify early indicators of cystic fibrosis pulmonary exacerbation onset |
Search more.